AI assistant
Sending…
ArcticZymes Technologies — Share Issue/Capital Change 2014
Apr 9, 2014
3538_rns_2014-04-09_f12139fc-5c7e-4ef2-ad6f-2909cdd8940e.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Biotec Pharmacon ASA - share capital increase registered in the Norwegian Register of Business Enterprises
Biotec Pharmacon ASA - share capital increase registered in the Norwegian Register of Business Enterprises
Reference is made to the stock exchange notice dated 8 April 2014
regarding the private placement completed on 7 April 2014.
The share capital increase approved by the Board in accordance with the
authorization granted by the General Meeting has been registered in the
Norwegian Register of Business Enterprises and the new shares have been
issued in VPS. The new registered share capital of Biotec Pharmacon ASA
is NOK 43 293 173 divided into NOK 43 293 173 shares each with a par
value of NOK 1.
More from ArcticZymes Technologies
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Interim / Quarterly Report
2026
May 7
Call Transcript
2026
May 7
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
AGM Information
2026
May 6
AGM Information
2026
May 6
Investor Presentation
2026
May 4
Environmental & Social Information
2026
Apr 30
Annual Report
2026
Apr 30